Dr. Bristow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 City Blvd West
Suite 1400
Orange, CA 92868Phone+1 714-456-8785
Education & Training
- Johns Hopkins UniversityMBA, Business Administration, 2003 - 2008
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gynecologic Oncology, 1995 - 1998
- Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1991 - 1995
- Keck School of Medicine of the University of Southern CaliforniaClass of 1991
Certifications & Licensure
- CA State Medical License 1995 - 2025
- MD State Medical License 1998 - 2010
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer Start of enrollment: 2000 Nov 20
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Join now to see all
Publications & Presentations
PubMed
- 188 citationsDisparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic StatusRobert E. Bristow, Matthew A. Powell, Noor Al-Hammadi, Ling Chen, J. Philip Miller
Journal of the National Cancer Institute. 2013-06-05 - 283 citationsOncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic reviewCamille C. Gunderson, Amanda N. Fader, Kathryn A. Carson, Robert E. Bristow
Gynecologic Oncology. 2012-05-01 - 20 citationsRacial-Ethnic and Socioeconomic Disparities in Guideline-Adherent Treatment for Endometrial Cancer.Victoria E. Rodriguez, Alana M. W. LeBrón, Jenny Chang, Robert E. Bristow
Obstetrics and Gynecology. 2021-07-01
Other
- Neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancerBristow RE, Konstantinopoulos PA
http://www.uptodate.com/contents/neoadjuvant-chemotherapy-for-newly-diagnosed-advanced-ovarian-cance
UpToDate, Wolters Kluwer Health - 2012-12-13
Press Mentions
- Widespread Flaws Found in Ovarian Cancer TreatmentFebruary 12th, 2016
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: